00:00It's Benzinga, bringing Wall Street to Main Street.
00:02President Trump announced new drug pricing agreements Monday with Astellas, B1 Medicines,
00:08CSL, Bridge Bio, Sun Pharmaceutical, and UCB, according to Reuters.
00:13The companies agreed to offer drugs to state Medicaid programs at most favored nation prices,
00:18though the White House did not disclose which medicines are covered or the size of the discounts.
00:23Some agreements also include plans for future savings on innovative drugs and increased U.S. manufacturing.
00:30The new agreements follow deals with 17 major drug makers, including Pfizer, Eli Lilly, and Novo Nordisk.
00:36The administration estimates its broader drug pricing efforts could save dollar billion in federal and state spending over the next
00:43decade.
00:44For all things money, visit Benzinga.com.
